NOV 1, 2026 · JOURNAL ARTICLE
Inhaled Nanomedicines for Lung Diseases and Injuries: Pharmacological Advances and Clinical Translation
Medcomm
ABSTRACT Respiratory diseases remain major causes of morbidity and mortality; however, inadequate pulmonary drug exposure and systemic toxicity continue to limit treatment efficacy